Apnimed, Inc. (APMD) Live Share Price, Invest From India

Apnimed, Inc. Stock Performance

as on October 31, 2026 at 3:26 am IST

Day's Low
Day's High
$16.33
Day's Price Range
$17.36
$16.39
0.37%
Downside
5.92%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$16.39
100.00%
Downside
-100.00%
Upside

Apnimed, Inc. share price movements today

Previous Close: $17.34
Open: $17.00
Volume: 399.2K
Market Cap: $797.2M
Day's Low - High: $16.33 - $17.36

Apnimed, Inc. Historical Returns

1 Month Return: -20.86 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Apnimed, Inc. Stock Fundamentals & Key Indicators

Check Apnimed, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$797.2M

EPS (TTM)

-0.06

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

2.65

PEG Ratio

0.00

EBITDA

35.9M

Revenue (TTM)

115.1M

Profit Margin

142.10%

Return On Equity TTM

0.00%

Apnimed, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Apnimed, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Apnimed, Inc.	StrongBuy	$797.2M	NA	2.65	142.10%	0.00%
Moderna	Neutral	$85.5B	-35.47%	-26.84	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Analyst Recommendation on Apnimed, Inc. Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Apnimed, Inc.. Average target price of $50.5

Apnimed, Inc. Share Price Target

Get share price movements and forecasts by analysts on Apnimed, Inc..

Current Price

$16.39

Analyzed by

3 Analysts

High

$60

Low

$41

Apnimed, Inc. target price $0, a slight upside of 0% compared to current price of $16.39. According to 3 analysts rating.

Indian Investors' Interest in Apnimed, Inc. Stock

Search interest for Apnimed, Inc. Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 30, 2026 to October 30, 2026

Change:-36% versus previous 30 day period

Apnimed, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2025	Jun 2025	Mar 2026	Jun 2026
Total Revenue	3	17	84	12
Gross Profit	1	15	82	10
Operating Income	-27	-5	68	-11
EBITDA	-27	-5	68	-11
Interest Expense	-	-	-	-
Depreciation	0	0	0	0
Income Before Tax	-26	-5	70	126
Income Tax Expense	-	-	-	-
Net Income	-28	-69	70	125
Net Profit Margin	-914.92%	-406.04%	82.97%	1042.51%

Apnimed, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	8	38
Gross Profit	4	31
Operating Income	-114	-53
EBITDA	-114	-53
Interest Expense	-	-
Depreciation	0	0
Income Before Tax	-108	0
Income Tax Expense	-	-
Net Income	-111	0
Net Profit Margin	-1389.23%	-2.42%

Apnimed, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Jun 2025	Mar 2026	Jun 2026
Net Income	-69	70	125
Operating Cash Flow	-17	-19	-18
Investing Cash Flow	-	-	-
Financing Cash Flow	16	24	44
Change in Cash	-1	4	125

Apnimed, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	0
Operating Cash Flow	-77
Investing Cash Flow	-
Financing Cash Flow	51
Change in Cash	-26

Global Institutional Holdings in Apnimed, Inc.

Check out the Institutions with significant holdings in Apnimed, Inc..

Funds	Holdings
Columbia Funds Series Trust II	17.29%
Vanguard	1.49%
iShares	1.09%
Fidelity Select Portfolios	0.22%
COLUMBIA FUNDS SERIES TRUST I	0.19%

See all

Insights on Apnimed, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 7 days, APMD stock has moved down by -8.7%

About Apnimed, Inc.

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Organisation	Apnimed, Inc.
Headquarters	39 John F. Kennedy Street, Cambridge, MA, 02138, US
Industry	Biotechnology
CEO	Kevin R. Lind

Key Management of Apnimed, Inc.

Name	Title
Ms. Leila Sylvain	Senior Manager of Administration
Mr. Steven W. Spector J.D.	Chief Legal Officer & Head of Corporate Affairs
Ms. Jennifer Patterson	Senior Vice President of Human Resources
Dr. John W. Cronin M.D.	Chief Medical Officer
Dr. Sean M. Johnston M.B.A., Ph.D.	Consulting Head of CMC
Dr. Lawrence G. Miller M.D., M.P.H.	Founder & Vice Chair of the Board
Mr. Dennis Patrick Molnar M.B.A.	President & COO
Mr. Michael B. Kelly	Chief Financial Officer
Mr. Kevin Robert Lind	CEO & Director
Dr. Luigi Taranto Montemurro M.D.	Co-Founder & Chief Scientific Officer

FAQs

What is Apnimed, Inc. share price today?

Apnimed, Inc. share price today is $16.39 as on October 30, 2026 at 9:56 pm IST. Apnimed, Inc. share today touched a day high of $17.36 and a low of $16.33.

What is the 52 week high and 52 week low for Apnimed, Inc. share?

Apnimed, Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Apnimed, Inc. stock price today i.e. October 30, 2026 at 9:56 pm IST is trending at $16.39,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Apnimed, Inc.'s market capitalisation today?

Apnimed, Inc. market capitalisation is $0.00T as on October 30, 2026 at 9:56 pm IST.

How to invest in Apnimed, Inc. Stock (APMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Apnimed, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Apnimed, Inc. Stock (APMD) from India?

Indian investors can start investing in Apnimed, Inc. (APMD) shares with as little as ₹94.94999694824219 or $1 (as of October 30, 2026 at 9:56 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Apnimed, Inc. stock (as per the Rupee-Dollar exchange rate as on October 30, 2026 at 9:56 pm IST). Based on Apnimed, Inc. share’s latest price of $16.39 as on October 30, 2026 at 9:56 pm IST, you will get 0.6101 shares of Apnimed, Inc.. Learn more about fractional shares .